Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease

This study has been completed.
Boehringer Ingelheim
United States Department of Defense
Information provided by:
Institute for Neurodegenerative Disorders Identifier:
First received: November 12, 2004
Last updated: September 28, 2010
Last verified: May 2007
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2007
  Estimated Primary Completion Date: No date given